In October 2018, the American Society of Radiation Oncologists (ASTRO) strongly endorsed moderately hypofractionated IMRT (20 or 28 treatments) for primary radiation treatment (see this link). … READ MORE …
Filed under: Uncategorized | Tagged: adverse, events, hypofractionation, safety, SBRT | 3 Comments »
It will come as no surprise to our readers that moderately hypofractionated IMRT (first-line radiation delivered in 20 to 26 treatments or fractions instead of the conventional 40-44 fractions) has received strong endorsement from all of the major US organizations of physicians who treat prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: guideline, hypofractionation, radiation, therapy | Leave a comment »
We now have data from an eighth randomized clinical trial of hypofractionated radiation therapy. There are no surprises: … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: hypofractionation, outcomes, radiation | Leave a comment »
There have been several hypofractionation trials maturing in the last couple of years. With minor exceptions, they all tell the same story: external beam radiation therapy (EBRT) can be completed in less time without loss of efficacy or increase in toxicity. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: effectiveness, hypofractionation, radiotherapy, safety | 8 Comments »
The HYPRO trial was designed to detect whether hypofractionation (fewer radiation treatments) was inferior to conventional fractionation (over about 8 weeks of treatment). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: erectile, function, hypofractionation, radiation, sexual | Leave a comment »
I was reticent to write about hypofractionation yet again after writing about it so often in the last year (see this link for my latest summary). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: hypofractionation, IMRT, outcomes, radiation, therapy | 1 Comment »
Within the past year, we have reviewed several major randomized clinical trials comparing hypofractionated radiation therapy to conventionally fractionated radiation therapy for primary treatment of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: hypofractionation, outcome, radiation, risk, therapy | 3 Comments »
We have recently seen Level 1 evidence that hypofractionation (fewer, more intense treatments) is no worse than conventional fractionation of intensity-modulated radiation therapy (IMRT). … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: hypofractionation, PBRT, proton, radiation | 1 Comment »
Reducing the number of radiation treatments but giving a slightly higher dose of radiation at each visit (“hypofractionation”) had no long-term differential effect on patients’ urinary, rectal, or sexual quality of life, … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: hypofractionation, outcome, quality of life, radiation, side effect | 3 Comments »
Salvage or adjuvant external beam radiation therapy for prostate cancer is usually a protracted affair, more so since we learned that a total dose of about 64 Gy to 70 Gy was needed to be effective in the salvage setting. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, hypofractionation, post-surgical, radiation, salvage, standard, stereotactic, therapy | 6 Comments »
This weekend’s news includes items on:
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, focal therapy, hypofractionation, outcomes, RALP, screening, sexual rehabilitation, training, trials | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 